Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06115265

Ketogenic Diet and Diabetes Demonstration Project

KDDP is a prospective, 12-month pilot study comparing the effects of a novel lifestyle program, the Ketogenic Diet and Diabetes Demonstration Project (KDDP) to those of the National Diabetes Prevention Program (NDDP). KDDP is modeled to mimic the delivery platform of NDPP with the exception that participants in KDDP will be placed on a medically-supervised ketogenic diet, and participants in NDPP will be placed on a low fat diet.

The purpose of this study is to compare the metabolic effects of the KDDP and the NDPP on glycemic control, lipid parameters, blood pressure, heart rate, weight, and coronary artery calcium scores in individuals with either type 2 diabetes or prediabetes.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

KDDP is a prospective, 12-month pilot study comparing the effects of the KDDP vs. CDC NDPP in patients with obesity and dysglycemia. KDDP is the Ketogenic Diet and Diabetes Demonstration Project arm. Individuals enrolled in the KDDP arm will attend a mandatory Weight Management class through the Center for Diabetes and Nutrition Education, and they will participate in a standard comprehensive lifestyle intervention program that is identical to that of the NDPP with the exception of dietary recommendations. Individuals in the KDDP arm will be educated on and follow a ketogenic diet (<20g carbohydrates/day). They will receive guidance on tracking carbohydrate intake daily, and home point-of-care ketone breath testing will be performed at regular intervals to ensure that ketosis is being achieved and maintained. They will attend weekly educational sessions facilitated by trained dieticians. Individuals enrolled in the CDC NDPP arm will adhere to a low fat diet and receive identical follow up with the dieticians relative to those enrolled in the KDDP arm. Individuals in both arms will be matched for age, sex, weight, and A1c.

Baseline measures at study entry will include weight, height, systolic and diastolic blood pressure, heart rate, hemoglobin A1c, fasting plasma glucose, total cholesterol, triglycerides, HDL cholesterol, and LDL cholesterol. These parameters will be measured every 3 months throughout the study and at study completion. Additionally, participants in both groups will be consented to undergo CAC scanning at baseline and at 12 months to assess for any differences in dietary interventions on CAC scores.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men and women ≥ 18 years old
  • BMI ≥27 kg/m2
  • Hemoglobin A1c ≥ 5.7% and/or fasting plasma glucose of 100-125 mg/dL

Exclusion criteria

  • Known clinical cardiovascular disease (i.e. prior stroke, myocardial infarction, peripheral artery disease)
  • LDL cholesterol ≥ 190 mg/dL
  • Triglycerides ≥ 500 mg/dL
  • History of type 1 diabetes
  • History of diabetic ketoacidosis
  • Individuals requiring insulin
  • Advanced renal disease
  • Advanced liver disease
  • Terminal cancer
  • Pregnancy

Treatment and study plan

Ketogenic diet

Behavioral

KDDP and NDPP will deliver identical comprehensive lifestyle counseling and follow up to participants, but dietary interventions in each group will differ, with KDDP participants receiving a ketogenic diet and NDPP participants receiving a low fat diet.

Low Fat Diet

Behavioral

KDDP and NDPP will deliver identical comprehensive lifestyle counseling and follow up to participants, but dietary interventions in each group will differ, with KDDP participants receiving a ketogenic diet and NDPP participants receiving a low fat diet.

Primary outcomes

  1. Weight in kg

    Time frame: 12 months

    Change in weight over 12-months in KDDP arm vs NDPP arm

Secondary outcomes

  1. Blood pressure in mmHg

    Time frame: 12 months

    Changes in the above measures from baseline to 12 months in KDDP arm vs. NDPP arm

  2. Heart rate in beats per minute (BPM)

    Time frame: 12 months

    Changes in heart rate from baseline to 12 months in KDDP arm vs. NDPP arm

  3. HbA1c as a percent

    Time frame: 12 months

    Changes in HbA1c from baseline to 12 months in KDDP arm vs. NDPP arm

  4. Fasting lipids in mg/dL

    Time frame: 12 months

    Changes in fasting lipids from baseline to 12 months in KDDP arm vs. NDPP arm

  5. Fasting plasma glucose in mg/dL

    Time frame: 12 months

    Changes in fasting plasma glucose from baseline to 12 months in KDDP arm vs. NDPP arm

  6. CAC scores

    Time frame: 12 months

    Changes in CAC scores from baseline to 12 months in KDDP arm vs. NDPP arm

Study contacts

Contact information is provided by the study sponsor or research team.

Kristen M Gonzales, MD

CONTACT

[email protected]

505-272-3840

Matthew Bouchonville, MD

CONTACT

[email protected]

505-272-3840

Sponsors and collaborators

Lead sponsor

University of New Mexico

Other

Registry information

Acronym: KDDP

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Nov 2, 2023
Registry last updated
Jun 30, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.